Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Neurovirol. 2021 Jul 31;27(4):519–530. doi: 10.1007/s13365-020-00920-6

Fig. 3.

Fig. 3.

Average CES-D item scores for each subgroup pre- and post-antiretroviral (ART). Green corresponds to symptom improvement with ART and magenta with symptom exacerbation with ART.